Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares - correction

3rd Mar 2026 16:31

RNS Number : 1850V
Maven Income and Growth VCT 5 PLC
03 March 2026

Maven Income and Growth VCT 5 PLC (the Company)

Correction to Share Buy-back and Total Voting Rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, and in order to correct a previous understatement in the announcement of the Transaction in Own Shares on 26 February 2026, which stated that 2,669,710 Ordinary shares of 10p each had been bought back by the Company for cancellation, rather than the correct figure of 2,699,710 Ordinary shares of 10p each. Due to the understatement of the transaction by 30,000 Ordinary shares of 10p, the Company confirms that its issued share capital at the close of business on 26 February 2026 comprised 250,941,935 Ordinary shares of 10p each.

The above understatement also resulted in the issued share capital and total voting rights figures included in the announcement of the Transaction in Own Shares which took place on 27 February 2026 being overstated by 30,000 Ordinary shares of 10p each. The Company confirms that its issued share capital at the close of business on 27 February 2026 comprised 250,876,085 Ordinary shares of 10p each.

Each share carries one voting right. Therefore, the total number of voting shares in the Company is 250,876,085.

The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure and Transparency Rules, to notify their interest, or a change to their interest, in the Company.

For further information, please email [email protected]

For and on behalf of the Company

Maven Capital Partners UK LLP

Tel: 0141 306 7400

3 March 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSQXLFBQXLLBBK

Related Shares:

Maven I&g Vct5
FTSE 100 Latest
Value10,484.13
Change-295.98